March 18, 2020

OREM, UT and REDWOOD CITY, CA - March 13, 2020 - KLAS, the leader in healthcare IT research, issued a spotlight report on Suki that concludes the digital assistant expedites accurate clinical documentation for physicians and enables them to make better decisions and experience an improved quality of life.  The assessment was based on interviews with Suki users across multiple specialties and evaluated Suki based on KLAS’s proprietary framework of product functionality, partnership, and overall customer satisfaction.

The report indicates that Suki customers are highly satisfied with the solution.  Notable findings from the report include:

  • “Product functionality” received an A score. Customers consistently mentioned Suki’s ability to provide accurate, detailed documentation with speed and mobility. One user commented, “Nobody in my field can produce notes as detailed as mine. The decision-making is so far beyond that it doesn’t even compare."
  • “Executive involvement” received an A score. Customers appreciated the attention they received from the Suki leadership team; in addition, 100% of respondents said they experienced immediate results after a short training meeting (<30 minutes) with their account manager.
  • “Would recommend to a friend” received an A+ score.  In addition, 100% of respondents indicated they would purchase Suki again.

“Based on our experience evaluating healthcare IT solutions, we are impressed with Suki’s ability to deliver immediate benefit to physicians, and the strong loyalty physicians have to the product.  Suki is tackling the difficult solution of administrative burden and has built a powerful tool that frees up physician time,” said Doug Tolley, VP of Business Development at KLAS and report author.

“We’re extremely pleased to learn the findings of the KLAS report,” said Punit Soni, CEO and founder of Suki.  “One of our core values is we build every pixel to be in the service of the doctor, and it’s gratifying to hear our users are seeing the value.  However, documentation is just the beginning - we’ll be tackling additional administrative challenges such as orders and billing and coding, and are excited to deliver even more value to users.”

The KLAS Spotlight report comes during a period of significant growth and success for Suki.  Suki recently announced it closed a Series B financing round of $20M and was selected by Fast Company as the #3 most innovative company in the health category earlier this week.

About KLAS

KLAS is a data-driven company on a mission to improve the world's healthcare by enabling provider and payer voices to be heard and counted. Working with thousands of healthcare professionals, KLAS collects insights on software, services and medical equipment to deliver reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly reflects the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit

About Suki

Suki is a voice-enabled digital clinical assistant for doctors that lifts the burden of medical documentation and administrative tasks. Powered by artificial intelligence and natural language processing, Suki creates clinically accurate medical notes and quickly completes administrative tasks such as retrieving patient information from the electronic health record (EHR). Suki understands physicians, adapting to their specialty, clinical setting, and speaking style, becoming more personalized as they use it. Used in dozens of specialties, including family medicine, gynecology, orthopedics, ophthalmology, and cardiology, Suki has been shown to decrease claims denial rates by up to 19 percent by generating highly detailed clinical documentation 76 percent faster. Suki’s team includes technologists from Apple, Google, IBM Watson, and McKinsey, and physicians from the University of California, San Francisco and Stanford. Suki is backed by premier investors such as Venrock, First Round, Flare Capital Partners, Breyer Capital and Marc Benioff. To learn more, visit, or follow us on AngelListFacebookLinkedIn, and Twitter.

RECENT content